Valproic acid Terminated Phase 2 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01900730Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter
NCT01010854Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer